Anlotinib Therapy in Patients With Advanced Lung Cancer.
NCT03940404
·
clinicaltrials.gov ↗
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Lung Neoplasms
Interventions
DRUG:
Anlotinib Hydrochloride
Sponsor
First People's Hospital of Hangzhou
Collaborators
[object Object]